Pharma shares today gained on foreign buying and management commentary.
Lupin gained 3.5 per cent, Glenmark Pharmaceuticals was up 2.3 per cent, while Cipla surged 5 per cent.
Foreign buying, robust management commentary in post results conference call were cited as reason by analysts.
The Reserve Bank of India has said that foreign investors can invest up to 49 per cent in Lupin.
Cipla’s results were below estimates but the management commentary on Teva JV and Jay Precision acquisition provided comfort, analysts said.
Cipla Q3 profit was up 15.5 per cent.
Glenmark's results adjusted for rouble’s impact were decent, an analyst with a foreign broker said.
Glenmark Q3 profit was down 48 per cent.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.